Improve patients' lives by timely providing them with

quality and affordable protein therapeutics

Honor
  • 2019
    China Youth "2019 PR Influence Top 20 Startup in Pharmaceutical Industry"
  • 2019
    ZJ Science City "Outstanding Listed Company"
  • 2019
    The 4th Jin Gang Gu "The Most Valuable Pharmaceutical Enterprise"
  • 2019
    The 8th Charity Festival  "Innovative CSR Activity Award"
  • 2019

    Sina Medical - Wisdom Growing Forum "The Most Valued Biopharmaceutical Enterprise"

  • 2019

    Sina Medical - Wisdom Growing Forum "The Best Charity Event in BioPharm Industry"

  • 2019
    Vcbeat Net "Future Healthcare VB 100"
  • 2019
    ONE FOSUN CSR Week "Special CSR Activity - Understanding Lymphoma: A Medical Education Charity Event"
  • 2019

    Global Generics & Biosimilars Awards  "Company of the Year,Asia Pacific - Finalist"

  • 2019
    Global Generics & Biosimilars Awards 2019 "Biosimilar Initiative of the Year - 漢利康®
  • 2019

    ZCCS "The Most Innovative Award"

  • 2019
    Equal Ocean "China Healthcare Industry Award - the Best Innovative Biopharmaceutical Enterprise"
  • 2019
    Frost & Sullivan  "China New Economy Award - Excellence in Innovation"
  • 2019
    MENET, Medicine Economic Reporter "Top 20 Biopharmaceutical Company in China"
  • 2019

    The 8th China Finance Summit "The Most Innovative Enterprise"

  • 2019

    Trade Union of Xuhui District, Science and Technology Commission of Xuhui District "2019 Xuhui District Innovation Centre for Science & Technology Contest Finalist"

  • 2019
    China Financial Market "Excellent Biopharmaceutical Enterprise" 
  • 2019
    Forbes China "The Most Innovative Companies in China"
  • 2019
    JRJ.com "Future Company of BioPharm Industry"
  • 2019
    Shanghai Worker Pioneer HLX01 Core Project Team
  • 2018
    Sina Medical "The Most Innovative Enterprise in Pharmaceutical Industry in 2018 China"
  • 2018
    Social Responsibility Conference "2018 Branding Award"
  • 2018
    Chinese Pharmaceutical Association "The Fast-growing Pharmaceutical Enterprise of Science and Technology Innovation in 2018"
  • 2018

    Ernst & Young "The Most Promising Enterprises in China"

  • 2018
     Vcbeat Net "Top of 2018 Future Medicine 100"
  • 2018

    Venture 50 "China Top 50 Investments for Value "

  • 2018

    China Business Journal "The Most Innovative Enterprise in Health Industry"

  • 2018

    The 7th China Finance Summit "The Most Innovative Enterprise"

  • 2018
    China Entrepreneur "Future Stars"
  • 2018

    Science and Technology Innovation Award for Songjiang Manufacturing Facility

  • 2018

    China Healthcare Consulting Group(CHC)-CITIC Securities "2017 Top Venture in Medical and Health"

  • 2018

    Life Science & Healthcare Unicorn Enterprise in Pudong New Area, Shanghai

  • 2018

    Innovative Startup Top 20 in Pudong New Area

  • 2018

    Haoyue Capital "Annual Best Venture Case in Biopharm "

  • 2018

    IMAPAC "Bioprocessing Innovations in Single-use Manufacturing in China"

  • 2018

    BioPharma "Asia Biotech of 2017"

  • 2017
    Life Science & Healthcare Unicorn Enterprise in China
  • 2017

    Deloitte Touche Tohmatsu "2017 Future Star in the China Pharma Industry"

  • 2017

    IMAPAC "Leading Innovations in Cutting-edge Technologies for Novel mAb Development & Production"

  • 2017

    IMAPAC "Best Bioprocessing Excellence in China"

  • 2017

    Specialized & Innovative SME

  • 2016

    Hign and New Technology Enterprises

Global Generics & Biosimilars Awards 2019
"Biosimilar Initiative of the Year - 漢利康?"

Generics Bulletin & IQVIA


The Most Innovative Companies in China

Forbes China

Asia Biotech of 2017

BioPharma

Bioprocessing Innovations in Single-use Manufacturing in China
Development & Production

IMAPAC

Excellent Biopharmaceutical Enterprise

China Financial Market

Subsidies for Research Projects
  • 2011

    National Major New Drug Research & Development Project in the 12th Five-year Plan

  • 2012

    National Major New Drug Research & Development Project in the 12th Five-year Plan

  • 2015
    Shanghai Industry Transformation and Upgrade Program (Biopharmaceutical Commercial-scale Facility)
  • 2018

    Shanghai Industry Transformation and Upgrade Program (Projects to Build a Robust Foundation for Industrial Development)

  • 2018

    Technology Giant Enterprise

  • 2018

    National Major New Drug Research & Development Project in the 13th Five-year Plan - Two Projects

  • 2018
    Shanghai Anti-tumour Biologic Medicine Engineering and Technology Research Centre Listed in Project Plan for Shanghai Engineering and Technology Research Centre
  • 2019
    National Major New Drug Research & Development Project in the 13th Five-year Plan
  • 2020
    Songjiang Manufacturing Facility Listed among Shanghai Major Construction Projects 
制作小米手机主题赚钱 三元股票 福建体彩36选7今天开 众发娱乐棋牌 福建11选5任选一怎么样 六台宝典旧版 股票开户软件哪个好 广西快3开奖l结果 中国体育彩票app 今晚广东36选7开奖号码 香港多多宝精选资料